Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Strategies focused on the HA stem advance universal influenza vaccine development

Aug. 27, 2015

Novel nanoparticle-based Epstein-Barr virus vaccine elicits potent antibody responses

Aug. 27, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

Jacobus Pharmaceutical reports development of novel antimalarials

Aug. 25, 2015

Motif Bio's iclaprim shows in vitro efficacy against S. aureus

Aug. 24, 2015

Genentech and Roche disclose anti-influenza MAbs

Aug. 24, 2015

FDA grants orphan drug designation to SER-109 for CDI in adults

Aug. 24, 2015

Preclinical efficacy of a human monoclonal antibody against influenza A virus

Aug. 24, 2015

60 Degrees Pharmaceuticals and Singapore General Hospital to test celgosivir in dengue fever

Aug. 24, 2015

Biota advances RSV program with start of phase I trial of BTA-585

Aug. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...